Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer.
Hu J, Yu A, Othmane B, Qiu D, Li H, Li C, Liu P, Ren W, Chen M, Gong G, Guo X, Zhang H, Chen J, Zu X.
Theranostics. 2021 Jan 1;11(7):3089-3108. doi: 10.7150/thno.53649. eCollection 2021.
FGFR inhibition augments anti-PD-1 efficacy in murine FGFR3-mutant bladder cancer by abrogating immunosuppression.
Okato A, Utsumi T, Ranieri M, Zheng X, Zhou M, Pereira LD, Chen T, Kita Y, Wu D, Hyun H, Lee H, Gdowski AS, Raupp JD, Clark-Garvey S, Manocha U, Chafitz A, Sherman F, Stephens J, Rose TL, Milowsky MI, Wobker SE, Serody JS, Damrauer JS, Wong KK, Kim WY.
J Clin Invest. 2024 Jan 16;134(2):e169241. doi: 10.1172/JCI169241.
Intravesical bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomised, placebo-controlled, double-blind clinical trial.
Leitner L, Ujmajuridze A, Chanishvili N, Goderdzishvili M, Chkonia I, Rigvava S, Chkhotua A, Changashvili G, McCallin S, Schneider MP, Liechti MD, Mehnert U, Bachmann LM, Sybesma W, Kessler TM.
Lancet Infect Dis. 2021 Mar;21(3):427-436. doi: 10.1016/S1473-3099(20)30330-3. Epub 2020 Sep 16.
Compact Arterial Monitoring Device Use in Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA): A Simple Validation Study in Swine.
Lussier G, Evans AJ, Houston I, Wilsnack A, Russo CM, Vietor R, Bedocs P.
Cureus. 2024 Oct 3;16(10):e70789. doi: 10.7759/cureus.70789. eCollection 2024 Oct.
Ultrasound versus Nerve Stimulator Guided Obturator Nerve Block in Patients Undergoing Transurethral Resection of Bladder Tumor.
Baral BK, Poudel PR, Rajbhandari M, Karki AJ, Dhakal GR.
J Nepal Health Res Counc. 2023 Jul 20;20(4):998-1002. doi: 10.33314/jnhrc.v20i4.4523.
Placenta Previa Accreta Spectrum: Cesarean Hysterectomy.
Takeda S, Takeda J, Murayama Y.
Surg J (N Y). 2021 May 25;7(Suppl 1):S28-S37. doi: 10.1055/s-0040-1721492. eCollection 2021 Dec.
Outcome of transurethral resection of bladder tumour under spinal anaesthesia combined with obturator nerve block in Sri Lanka.
Ambegoda M, Shiyanth S, Vidanapathirana S, Kumara S, Gunaratne A, Abeygunasekera A.
Urologia. 2023 Feb;90(1):80-82. doi: 10.1177/03915603221127843. Epub 2022 Nov 3.
Mini-Review: Current Bladder Cancer Treatment-The Need for Improvement.
Gill E, Perks CM.
Int J Mol Sci. 2024 Jan 26;25(3):1557. doi: 10.3390/ijms25031557.
Properties of FDA-approved small molecule protein kinase inhibitors: A 2020 update.
Roskoski R Jr.
Pharmacol Res. 2020 Feb;152:104609. doi: 10.1016/j.phrs.2019.104609. Epub 2019 Dec 17.
Invasive urodynamic investigations in the management of women with refractory overactive bladder symptoms (FUTURE) in the UK: a multicentre, superiority, parallel, open-label, randomised controlled trial.
Abdel-Fattah M, Chapple C, Cooper D, Breeman S, Bell-Gorrod H, Kuppanda P, Guerrero K, Dixon S, Cotterill N, Ward K, Hashim H, Monga A, Brown K, Drake M, Gammie A, Mostafa A, Bruce R, Bell V, Kennedy C, Evans S, MacLennan G, Norrie J; FUTURE Study Group.
Lancet. 2025 Mar 29;405(10484):1057-1068. doi: 10.1016/S0140-6736(24)01886-5. Epub 2025 Mar 22.
